In contrast, a small molecule inhibitor of the MST1R (RON) tyrosine kinase domain (LCRF-0004) had significant effects on mesothelioma cellular proliferation and health, and cell cycle progression (Figures 5–7), and additions of exogenous MST1 were unable to abrogate these effects. Here, MST1R is linked to mesothelioma.